Miao Robert Q, Fontana Jason, Fulton David, Lin Michelle I, Harrison Kenneth D, Sessa William C
Department of Pharmacology and Vascular Biology and Therapeutics Program, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536, USA.
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):105-11. doi: 10.1161/ATVBAHA.107.155499. Epub 2007 Nov 1.
Heat-shock protein 90 (Hsp90) coordinates the regulation of diverse signaling proteins. We try to develop a new tool to explore the regulatory functions of Hsp90 in endothelial cells (ECs) instead of the existing chemical approaches.
We designed a dominant-negative Hsp90 construct by site-direct mutagenesis of residue Asp-88 to Asn (D88N-Hsp90) based on the structure of the ATP/ADP-binding site. Recombinant wild-type Hsp90 protein binds ATP-Sepharose beads in manner inhibited by ATP or 17-AAG, a specific inhibitor for Hsp90, however the binding activity of D88N-Hsp90 was markedly reduced and the inhibitory effects of ATP or 17-AAG were negligible. The dimerization between endogenous Hsp90alpha and exogenous HA-Hsp90beta was confirmed by immunoprecipitation, however the association between eNOS and D88N-Hsp90 was less than WT-Hsp90. Furthermore, adenoviral transduction of bovine aortic ECs with D88N-Hsp90 suppressed VEGF-induced phosphorylation of Akt, eNOS, and NO release and the inhibitory effect was blocked by okadaic acid. Moreover, D88N-Hsp90 abolished VEGF-stimulated Rac activation and suppressed VEGF-induced stress fiber formation. Transduction with D88N-Hsp90 decreased growth medium mediated migration of wild-type ECs, but not Akt1(-/-) ECs suggesting that Akt is key target of Hsp90.
Our data demonstrate that dominant-negative Hsp90 modulates endothelial cell mobility mainly through PP2A-mediated dephosphorylation of Akt and Rac activation.
热休克蛋白90(Hsp90)协调多种信号蛋白的调节。我们试图开发一种新工具来探索Hsp90在内皮细胞(ECs)中的调节功能,而非现有的化学方法。
基于ATP/ADP结合位点的结构,我们通过将天冬氨酸残基88突变为天冬酰胺(D88N-Hsp90)设计了一种显性负性Hsp90构建体。重组野生型Hsp90蛋白以被ATP或17-AAG(一种Hsp90特异性抑制剂)抑制的方式结合ATP-琼脂糖珠,然而D88N-Hsp90的结合活性明显降低,且ATP或17-AAG的抑制作用可忽略不计。通过免疫沉淀证实了内源性Hsp90α与外源性HA-Hsp90β之间的二聚化,然而内皮型一氧化氮合酶(eNOS)与D88N-Hsp90之间的关联小于野生型Hsp90。此外,用D88N-Hsp90对牛主动脉内皮细胞进行腺病毒转导可抑制血管内皮生长因子(VEGF)诱导的Akt、eNOS磷酸化及一氧化氮(NO)释放,且冈田酸可阻断这种抑制作用。此外,D88N-Hsp90消除了VEGF刺激的Rac激活并抑制了VEGF诱导的应力纤维形成。用D88N-Hsp90转导可降低生长培养基介导的野生型内皮细胞迁移,但对Akt1基因敲除(-/-)内皮细胞无此作用,提示Akt是Hsp90的关键靶点。
我们的数据表明,显性负性Hsp90主要通过蛋白磷酸酶2A(PP2A)介导的Akt去磷酸化和Rac激活来调节内皮细胞迁移。